Trials / Unknown
UnknownNCT01679340
A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
Phase Ⅱ Study of S-1 Combined With Oxaliplatin (SOX)Verse S-1 Combined With Cisplatin(SP) in Adjuvant Chemotherapy After D2 Surgery
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficiency and safety of SOX or SP adjuvant chemotherapy to phase II and III gastric cancer patients after D2 surgery. If SOX is equal to SP in efficiency and less toxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-1 | Mode of administration: orally (capsules) Dosing schedule:80mg/m2, Bid,D1-14,every 3 week,for 8-10cycles |
| DRUG | oxaliplatin | Mode of administration: intravenously Doseing schedule: 65 mg/m2 D1,D8,every 3 week, for 6 cycles |
| DRUG | cisplatin | Mode of administration: intravenously Dosing schedule: 75mg/m2 D1,every 3 week,for 6 cycle |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2018-03-01
- Completion
- 2018-06-01
- First posted
- 2012-09-06
- Last updated
- 2015-05-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01679340. Inclusion in this directory is not an endorsement.